Proteomic Analysis of Synovial Fluid Obtained From a Dog Diagnosed With Idiopathic Immune-Mediated Polyarthritis.

This case study is to report the proteins detected by proteomic analysis of synovial fluid from a dog diagnosed with idiopathic immune-mediated polyarthritis, and to compare it with healthy dogs. Synovial fluid was collected via arthrocentesis from a dog diagnosed with immune-mediated polyarthritis. Protein precipitation was performed on the synovial fluid, followed by isoelectric focusing and 2-dimensional gel electrophoresis. The spots on the 2-dimensional gels were analyzed using MALDI-TOF/MS. The results were then analyzed against the MASCOT database. The results from the proteomic analysis revealed an abundance of several types of immunoglobulins together with the presence of complement C4b-binding protein alpha chain. Actin and keratin were also among the proteins detected. Proteomic studies, facilitate a better understanding of the different levels of proteins expressed during disease activity. Potential disease biomarkers can aid in the diagnosis of disease, as well as help in monitoring treatment efficacy and providing prognosis for the patient.

[1]  T. Yonezawa,et al.  Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis , 2015, The Journal of veterinary medical science.

[2]  L. Trepanier,et al.  Serum Biomarkers of Clinical and Cytologic Response in Dogs with Idiopathic Immune‐Mediated Polyarthropathy , 2014, Journal of veterinary internal medicine.

[3]  A. Mackin,et al.  Canine immune-mediated polyarthritis: part 2: diagnosis and treatment. , 2012, Journal of the American Animal Hospital Association.

[4]  A. Mackin,et al.  Canine immune-mediated polyarthritis: part 1: pathophysiology. , 2012, Journal of the American Animal Hospital Association.

[5]  D. Bennett.  Immune-mediated and infective arthritis , 2010 .

[6]  H. Tsujimoto,et al.  C-reactive protein concentration in canine idiopathic polyarthritis. , 2006, The Journal of veterinary medical science.

[7]  G. Herrero-Beaumont,et al.  Expression of the peptide C4b-binding protein β in the arthritic joint , 2006 .

[8]  T. Hughes,et al.  Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. , 2006, Molecular immunology.

[9]  G. Herrero-Beaumont,et al.  Expression of the peptide C4b-binding protein beta in the arthritic joint. , 2006, Annals of the rheumatic diseases.

[10]  R. Abagyan,et al.  Insights into the Human CD59 Complement Binding Interface Toward Engineering New Therapeutics* , 2005, Journal of Biological Chemistry.

[11]  P. Gasque.  Complement: a unique innate immune sensor for danger signals. , 2004, Molecular immunology.

[12]  D. Woolley,et al.  Synthesis of classical pathway complement components by chondrocytes. , 1996, Immunology.

[13]  J. Levick,et al.  Fluid movement across synovium in healthy joints: role of synovial fluid macromolecules. , 1995, Annals of the rheumatic diseases.

[14]  J. Dacre,et al.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease. , 1991, Annals of the rheumatic diseases.

[15]  D. Bennett.  Immune-based non-erosive inflammatory joint disease of the dog. 3. Canine idiopathic polyarthritis , 1987 .

[16]  D. Kelly,et al.  Immune‐based non‐erosive inflammatory joint disease of the dog. 2. Polyarthritis/polymyositis syndrome , 1987 .